The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index; 21 of the 34 sources its claims cite were checked for support.
Connecting proteomics and genomics to identify causal biomarkers specific for aortic valve stenosis
Open accessAbstract
Abstract Introduction Aortic valve stenosis (AS) is a progressive disease characterized by the calcification and narrowing of the aortic valve, leading to significant morbidity and mortality. Early detection and risk stratification remain a major clinical challenge. Identifying specific biomarkers could significantly improve risk prediction and disease management. Objective This study aims to (1) identify novel plasma protein biomarkers for incident AS, (2) establish causal relationships using genetic approaches, and (3) prioritize biomarkers specific to the aortic valve tissue. Methods We assessed the association between 2,923 unique plasma proteins measured using the Olink Explore assay and AS incidence in 52,632 UK Biobank participants with 487 incident AS cases over a median follow-up of 13 years. Multivariable Cox proportional hazards models were used to evaluate associations adjusted for cardiovascular risk factors. A stratified analysis was performed to investigate the association in men and women separately. For causal inference, we used protein quantitative trait loci (pQTL) Mendelian Randomization (MR). We then verified the aortic valve specificity of the proteins using our transcriptomic dataset of 500 human aortic valves. Using expression QTL (eQTL)-based MR, we evaluated the causal role of gene expression in AS and performed colocalization analyses. Results Our fully adjusted model identified 55 proteins significantly associated with AS incidence, with GDF15 showing the strongest association (HR=1.93 per SD, 95% CI: 1.67–2.23, P value = 3.3E-19). In sex-stratified analyses, 10 proteins showed a significant association with AS incidence in women, including 5 more strongly associated in women (CD38, CD80, IGFBPL1, NFASC, SERPINA9, P interaction <0.05), whereas 16 proteins were identified in men including 1 protein (REG1A) with a significantly stronger association in men. pQTL-MR suggested a potential causal role for 4 proteins (PCSK9, CHI3L1, NFASC, PRSS8). Transcriptomic integration confirmed high aortic valve expression for 11 candidates, with three genes demonstrating significant associations in aortic valve eQTL MR analyses, including LTBP2, for which the pQTL and eQTL colocalized. Conclusion The integration of proteomics and genomics allowed the identification of potential biomarkers and drug targets for AS, showing evidence of causality and tissue-specific expression.
Overview
CoChat Summary
TL;DR
In 52,632 UK Biobank participants with 487 incident aortic valve stenosis (AS) cases, 55 plasma proteins were associated with AS after full adjustment, and integration with pQTL/eQTL Mendelian randomization and aortic valve transcriptomics prioritized potentially causal, valve-specific candidates including PCSK9, LTBP2, COL4A1, and B2M.
Key findings
- In the fully adjusted Cox model (age, sex, BMI, smoking, eGFR, ancestry, SBP, LDL-C), 55 of 2,923 Olink proteins were significantly associated with incident AS; GDF15 was strongest (HR = 1.93 per SD, 95% CI 1.67–2.23, P = 3.26E-19). The base model (age, sex) identified 424 proteins (406 positive, 18 negative), with GDF15 at HR = 2.25 per SD (95% CI 2.02–2.52, P = 3.79E-46).
- Sex-stratified analyses found 10 significant proteins in women (n = 28,451; strongest IGFBP7, HR = 2.25 per SD, 95% CI 1.70–2.98, P = 1.49E-08) and 16 in men (n = 24,181; strongest GDF15, HR = 2.06 per SD, 95% CI 1.73–2.45, P = 8.09E-16). Six proteins met both sex-stratified significance and interaction criteria: 5 female-predominant (CD38, CD80, IGFBPL1, NFASC, SERPINA9) and 1 male-specific (REG1A).
- pQTL-MR among the 55 fully adjusted proteins identified 4 with robust causal evidence: PCSK9 (OR = 1.18 per SD, 95% CI 1.12–1.24, P = 2.66E-10), CHI3L1 (OR = 1.03, 95% CI 1.02–1.05, P = 6.42E-5), NFASC (OR = 1.06, 95% CI 1.02–1.10, P = 0.005), and PRSS8 (OR = 1.32, 95% CI 1.07–1.64, P = 0.01).
- Eleven genes showed high aortic valve expression (>78 TPM); eQTL-MR was significant for COL4A1 (OR = 1.32 per SD, 95% CI 1.10–1.59, P = 0.003), LTBP2 (OR = 1.21, 95% CI 1.05–1.40, P = 0.01), and B2M (OR = 1.21, 95% CI 1.07–1.36, P = 0.02). Only LTBP2 colocalized between aortic valve eQTLs and plasma pQTLs (PP.H4 = 0.93), and between valve and aorta eQTLs (PP.H4 = 0.88); COL4A1 and B2M showed PP.H4 < 0.5. Six of ten prioritized genes had DGIdb interaction scores >0.1, with approved agents targeting B2M, COL4A1, PCSK9, REG1A, and REN.
Methods
- Prospective cohort study in UK Biobank Pharma Proteomics Project participants (n = 52,632; 54.1% female), with 2,923 unique plasma proteins measured by Olink Explore and incident AS defined by ICD codes I35.0/I35.2 over a median 13-year follow-up (487 cases). Multivariable Cox proportional hazards models (base and fully adjusted) with Bonferroni threshold P < 1.7E-5, plus sex-stratified and sex-interaction analyses; pathway enrichment via Metascape.
- Two-sample MR using deCODE pQTLs (SomaScan, 35,559 Icelanders) as exposure and an AS GWAS meta-analysis (14,819 cases, 927,044 controls) as outcome; cis-variants within 500 kb, LD clumping r² < 0.1, minimum 3 instruments, IVW primary with weighted median and MR-Egger sensitivity analyses.
- Aortic valve specificity assessed by bulk RNA-seq of 500 human aortic valves (60 healthy from transplant recipients, 440 diseased from AVR patients); cis-eQTL MR (±500 kb, FDR < 5%) for highly expressed genes, Bayesian colocalization (COLOC v3.2.1, PP.H4 > 0.75 threshold) with UKB-PPP pQTLs and GTEx aorta eQTLs, and druggability via DGIdb v5.0.
Limitations
- Stated: analysis focused mainly on European ancestry (93.2%), limiting generalizability; sex-stratified GWAS summary statistics were unavailable, so MR was performed in a combined sample and may obscure sex-specific genetic effects; functional validation and mechanistic in vitro/in vivo studies are required to confirm findings.
- Evident from the text: the observational cohort had only 487 incident AS cases, and the MR instrument set was reduced (325 of 424 base-model proteins available in deCODE; 180 retained after requiring ≥3 variants), which limits power; the pQTL and eQTL analyses used different cohorts and platforms (deCODE SomaScan vs UKB-PPP Olink), and X/Y chromosome proteins were excluded.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
19 Valid · 1 Not valid · 7 Not checked · 66 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These findings are in line with prior evidence linking lipid metabolism and extracellular matrix remodeling to valve calcification, particularly in male 9,34,35 individuals”
What the sources say
- Not checked — no full text of the sourcecites [9] source
- Partly supportedcites [34] sourceExperimental — accuracy not yet measured
The Discussion reports that men may undergo more calcification and fibrosis than women at a similar severity of stenosis, offering qualified support for the male-specific remodeling point. It does not link lipid metabolism to valve calcification; the Limitations say the underlying histologic determinants of the sex difference were beyond the study’s scope. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [35] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Statistically significant eQTLs were identified using a false discovery rate (FDR) P value threshold of < 5% 11 .”
What the sources say
- Supportedcites [11] source
The Methods section, “Expression quantitative trait loci (eQTL) in aortic valve,” states that nominal significance thresholds corresponding to an FDR below 5% were calculated for each gene and used to identify significant eQTLs. This supports the cited threshold, though the paper describes it as a gene-specific nominal significance threshold rather than a single P-value cutoff. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Integrating proteomic data with Mendelian Randomization (MR) can strengthen causal inference by leveraging genetic variants as instruments.”
What the sources say
- Partly supportedcites [10] sourceExperimental — accuracy not yet measured
The paper’s “A method to overcome confounding > Concepts” section defines Mendelian randomisation as using genetic variants as instrumental variables to investigate causal effects. Its discussion of instruments supports that general rationale, but the passages found do not address integrating proteomic data with MR or whether that integration strengthens causal inference. (LLM, conf=0.86)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Since genetic variants are randomly allocated at conception, MR minimizes biases from confounding and reverse causation, which are common in traditional observational studies 10 .”
What the sources say
- Supportedcites [10] source
In “A method to overcome confounding” (page unavailable), the paper says genetic variants are fixed at conception and Mendelian randomisation can overcome some confounding in observational studies. The same section describes reverse causality as a difficult-to-address source of bias. The claim appropriately says MR minimizes, rather than eliminates, these biases; the paper notes that its inferences depend on assumptions. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“This approach has been used successfully to identify genes with a potentially causal association between expression in aortic valve tissues and AS 11 .”
What the sources say
- Supportedcites [11] source
The Results section (‘Transcriptome-wide association study, colocalization and Mendelian randomization’) reports that ten genes showed significant MR associations, suggesting a causal association between their expression in the aortic valve and calcific aortic valve stenosis. This directly supports the citing sentence’s qualified claim of a potentially causal association. (LLM, conf=0.94)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
37 more claims · 1 with their cited sources checked
Create a free account to see all 93 claims and every source verdict.
- Probably not a substantial claim. 29
- It may state two separate claims as one. 32
- The quote only partly states this claim. 3
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Mixed | 345 (0.6) | 1 (0.2) |”
Reported 0.6 · recomputed 0.661617
Citations
Cites
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A. H., Tanaseichuk, O., Benner, C., & Chanda, S. K. (2019) · Nature Communications · doi:10.1038/s41467-019-09234-6 · Cited by 14,611
Second-generation PLINK: rising to the challenge of larger and richer datasets
Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., & Lee, J. J. (2015) · Gigascience · doi:10.1186/s13742-015-0047-8 · Cited by 12,709
MultiQC: summarize analysis results for multiple tools and samples in a single report
Ewels, P., Magnusson, M., Lundin, S., & Käller, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw354 · Cited by 10,143
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816
Bowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922
The UK Biobank resource with deep phenotyping and genomic data
Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., O’Connell, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0579-z · Cited by 8,876
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab395 · Cited by 5,685
Self-citationThe GTEx Consortium atlas of genetic regulatory effects across human tissues
The GTEx Consortium, Aguet, F., Anand, S., Ardlie, K. G., Gabriel, S., Getz, G. A., Graubert, A., Hadley, K., Handsaker, R. E., Huang, K. H., et al. (2020) · Science · doi:10.1126/science.aaz1776 · Cited by 5,547 · cited 1×
“To determine whether the variants associated with gene expression and those associated with circulating protein levels were the same, we performed Bayesian colocalization analyses integrating aortic valve tissue eQTLs with pQTLs from the UKB-PPP 13 and aorta tissue eQTLs from GTEx (v8) 23 .”
Burden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881 · cited 1×
“These processes result in the fibrocalcific remodeling of aortic valve leaflets, ultimately leading to impaired blood flow 2,3 .”
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
Davies, N. M., Holmes, M. V., & Davey Smith, G. (2018) · BMJ · doi:10.1136/bmj.k601 · Cited by 4,404
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
Plasma proteomic associations with genetics and health in the UK Biobank
Sun, B. B., Chiou, J., Traylor, M., Benner, C., Hsu, Y.-H., Richardson, T. G., Surendran, P., Mahajan, A., Robins, C., Vasquez-Grinnell, S. G., et al. (2023) · Nature · doi:10.1038/s41586-023-06592-6 · Cited by 1,880
Large-scale integration of the plasma proteome with genetics and disease
Ferkingstad, E., Sulem, P., Atlason, B. A., Sveinbjornsson, G., Magnusson, M. I., Styrmisdottir, E. L., Gunnarsdottir, K., Helgason, A., Oddsson, A., Halldorsson, B. V., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00978-w · Cited by 1,697
2025 ESC/EACTS Guidelines for the management of valvular heart disease
Praz, F., Borger, M. A., Lanz, J., Marin-Cuartas, M., Abreu, A., Adamo, M., Ajmone Marsan, N., Barili, F., Bonaros, N., Cosyns, B., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf194 · Cited by 1,072
Lindman, B. R., Clavel, M.-A., Mathieu, P., Iung, B., Lancellotti, P., Otto, C. M., & Pibarot, P. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.6 · Cited by 982
Self-citationThe power of genetic diversity in genome-wide association studies of lipids
Graham, S. E., Clarke, S. L., Wu, K.-H. H., Kanoni, S., Zajac, G. J. M., Ramdas, S., Surakka, I., Ntalla, I., Vedantam, S., Winkler, T. W., et al. (2021) · Nature · doi:10.1038/s41586-021-04064-3 · Cited by 972
RNA-SeQC: RNA-seq metrics for quality control and process optimization
DeLuca, D. S., Levin, J. Z., Sivachenko, A., Fennell, T., Nazaire, M.-D., Williams, C., Reich, M., Winckler, W., & Getz, G. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts196 · Cited by 899
Aortic-Valve Stenosis — From Patients at Risk to Severe Valve Obstruction
Otto, C. M., & Prendergast, B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1313875 · Cited by 631
Warren, H. R., Evangelou, E., Cabrera, C. P., Gao, H., Ren, M., Mifsud, B., Ntalla, I., Surendran, P., Liu, C., Cook, J. P., et al. (2017) · Nature Genetics · doi:10.1038/ng.3768 · Cited by 551
Simard, L., Côté, N., Dagenais, F., Mathieu, P., Couture, C., Trahan, S., Bossé, Y., Mohammadi, S., Pagé, S., Joubert, P., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.309306 · Cited by 294
Self-citationAggarwal, S. R., Clavel, M.-A., Messika-Zeitoun, D., Cueff, C., Malouf, J., Araoz, P. A., Mankad, R., Michelena, H., Vahanian, A., & Enriquez-Sarano, M. (2013) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.112.980052 · Cited by 280 · cited 1×
“These findings are in line with prior evidence linking lipid metabolism and extracellular matrix remodeling to valve calcification, particularly in male individuals 9,34,35 .”
Self-citationBossé, Y., Miqdad, A., Fournier, D., Pépin, A., Pibarot, P., & Mathieu, P. (2009) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.108.820795 · Cited by 148 · cited 1×
“Notably, it was previously found to be upregulated in human calcified aortic valves and associated with increased mortality in individuals with aortic stenosis 39,40 .”
Self-citationSignificance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer
Yu, J. E., Yeo, I. J., Han, S.-B., Yun, J., Kim, B., Yong, Y. J., Lim, Y.-S., Kim, T. H., Son, D. J., & Hong, J. T. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01131-9 · Cited by 109 · cited 1×
“A significant causal effect was also observed for CHI3L1, a glycoprotein highly secreted by macrophages in inflammatory conditions 38 .”
COL4A1 Is Associated With Arterial Stiffness by Genome-Wide Association Scan
Tarasov, K. V., Sanna, S., Scuteri, A., Strait, J. B., Orrù, M., Parsa, A., Lin, P.-I., Maschio, A., Lai, S., Piras, M. G., et al. (2009) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.108.823245 · Cited by 104 · cited 1×
“A variant in COL4A1 was associated with increased arterial stiffness 44 .”
Thaden, J. J., Nkomo, V. T., Suri, R. M., Maleszewski, J. J., Soderberg, D. J., Clavel, M.-A., Pislaru, S. V., Malouf, J. F., Foley, T. A., Oh, J. K., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv560 · Cited by 104
Self-citationImpact of hypertension and renin–angiotensin system inhibitors in aortic stenosis
Capoulade, R., Clavel, M., Mathieu, P., Côté, N., Dumesnil, J. G., Arsenault, M., Bédard, É., & Pibarot, P. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12169 · Cited by 97 · cited 1×
“…targeted by renin–angiotensin inhibitors and clinical observations report that renin– angiotensin system blockade is associated with slower progression of aortic stenosis, reduction in left ventricular mass, and significant survival benefits in patients undergoing aortic valve replacement 47,48 .”
Self-citationGenetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis
Perrot, N., Valerio, V., Moschetta, D., Boekholdt, S. M., Dina, C., Chen, H. Y., Abner, E., Martinsson, A., Manikpurage, H. D., Rigade, S., et al. (2020) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2020.05.004 · Cited by 91
Self-citationCD38 promotes angiotensin II‐induced cardiac hypertrophy
Guan, X., Hong, X., Zhao, N., Liu, X., Xiao, Y., Chen, T., Deng, L., Wang, X., Wang, J., Ji, G., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13076 · Cited by 90
Genetic Regulation of Fibroblast Activation and Proliferation in Cardiac Fibrosis
Park, S., Ranjbarvaziri, S., Lay, F. D., Zhao, P., Miller, M. J., Dhaliwal, J. S., Huertas-Vazquez, A., Wu, X., Qiao, R., Soffer, J. M., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035420 · Cited by 85 · cited 1×
“In a different study, expression of LTBP2 was primarily localized within fibrotic regions of the myocardium during heart failure, suggesting its potential as a marker of cardiac fibrosis 42 .”
de Boer, O. J., Hirsch, F., van der Wal, A. C., van der Loos, C. M., Das, P. K., & Becker, A. E. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00135-4 · Cited by 85 · cited 1×
“…of atherosclerotic plaques from human arteries, including the descending aorta, revealed CD80 expression in macrophages and a small subset of T cells, predominantly localized to the fibrous cap, thereby linking CD80 expression to the inflammatory processes underlying plaque development 32 .”
Yang, W., Ng, F. L., Chan, K., Pu, X., Poston, R. N., Ren, M., An, W., Zhang, R., Wu, J., Yan, S., et al. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1006127 · Cited by 80 · cited 1×
“Variants in COL4A2 affect COL4A1 / COL4A2 expression, leading to smooth muscle cell apoptosis, thinner fibrous caps, and higher myocardial infarction risk 45 .”
di Candia, A. M., de Avila, D. X., Moreira, G. R., Villacorta, H., & Maisel, A. S. (2021) · American Heart Journal Plus: Cardiology Research and Practice · doi:10.1016/j.ahjo.2021.100046 · Cited by 79
Li, M., Duan, L., Cai, Y.-L., Li, H.-Y., Hao, B.-C., Chen, J.-Q., & Liu, H.-B. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01092-7 · Cited by 71
Schuermans, A., Pournamdari, A. B., Lee, J., Bhukar, R., Ganesh, S., Darosa, N., Small, A. M., Yu, Z., Hornsby, W., Koyama, S., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00567-0 · Cited by 71
Shi, F., Sun, L., & Kaptoge, S. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.01.018 · Cited by 70 · cited 1×
“B2M is associated with antigen presentation, inflammation, and the complement cascade, with elevated levels linked to cardiovascular events and mortality 46 .”
Conte, M., Petraglia, L., Campana, P., Gerundo, G., Caruso, A., Grimaldi, M. G., Russo, V., Attena, E., Leosco, D., & Parisi, V. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-020-01681-2 · Cited by 67 · cited 1×
“These findings align with prior evidence suggesting that chronic inflammation drives valvular calcification and sclerosis 24 .”
Janat, M. F., & Liau, G. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041500203 · Cited by 66
Boucherat, O., Yokokawa, T., Krishna, V., Kalyana-Sundaram, S., Martineau, S., Breuils-Bonnet, S., Azhar, N., Bonilla, F., Gutstein, D., Potus, F., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00113-w · Cited by 64 · cited 1×
“Through an integrated multi-omics analysis of human right ventricular tissues and plasma, LTBP2 was identified as a blood biomarker upregulated in failing heart tissue of individuals with pulmonary artery hypertension, correlating with cardiac fibrosis 41 .”
Thériault, S., Li, Z., Abner, E., Luan, J., Manikpurage, H. D., Houessou, U., Zamani, P., Briend, M., Estonian Biobank Research Team, Boudreau, D. K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46639-4 · Cited by 49
Self-citationGoel, S. S., Kleiman, N. S., Zoghbi, W. A., Reardon, M. J., & Kapadia, S. R. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016911 · Cited by 43
Large-scale proteomics identifies novel biomarkers and circulating risk factors for aortic stenosis
Shelbaya, K., Arthur, V., Yang, Y., Dorbala, P., Buckley, L., Claggett, B., Skali, H., Dufresne, L., Yang, T.-Y., Engert, J. C., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.11.021 · Cited by 41
YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic Stenosis
Arain, F., Abraityte, A., Bogdanova, M., Solberg, O. G., Michelsen, A. E., Lekva, T., Aakhus, S., Holm, S., Halvorsen, B., Finsen, A. V., et al. (2020) · Circulation: Heart Failure · doi:10.1161/circheartfailure.119.006643 · Cited by 13 · cited 1×
“Notably, it was previously found to be upregulated in human calcified aortic valves and associated with increased mortality in individuals with aortic stenosis 39,40 .”
Tan, X., Wang, X., Xu, S., Zeng, Y., Zhang, G., Xu, A., Jiang, Y., Jiang, H., Song, Y., Fan, J., et al. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s495784 · Cited by 8 · cited 1×
“Plasma REG1A has been shown to be elevated in acute myocardial infarction, indicating a role in cardiovascular stress response 33 .”
Great debate: symptomatic moderate aortic stenosis should undergo intervention
Bax, J. J., Hahn, R. T., Marsan, N. A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae050 · Cited by 8 · cited 13×
“In the absence of randomized clinical trials in symptomatic patients with moderate AS, there is an ongoing debate about the optimal management in this population 7 .”
InfluentialPlasma Proteomic Assessment of Calcific Aortic Valve Disease in Older Adults
Bortnick, A. E., Austin, T. R., Hamerton, E., Guðmundsdóttir, V., Emilsson, V., Jennings, L. L., Gudnason, V. G., Owens, D. S., Massera, D., Dufresne, L., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.036336 · Cited by 8
Basmadjian, L., Bouabdallaoui, N., Simard, F., O'Meara, E., Ducharme, A., Rouleau, J.-L., Racine, N., White, M., Sirois, M. G., Asgar, A., et al. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.09.029 · Cited by 6 · cited 1×
“As a stress-responsive cytokine, GDF15 is elevated in many cardiac disorders and may reflect underlying valvular pathological processes driven by chronic inflammation and oxidative stress 26–28 .”
Plasma Proteomic Biomarkers of Aortic Stenosis
Yang, T., Small, A. M., Dufresne, L., Peloso, G. M., Natarajan, P., Engert, J. C., & Thanassoulis, G. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.05.046 · Cited by 6 · cited 1×
“These findings further align with the more recent MR analysis by Yang et al., which also reported a robust causal effect of plasma PCSK9 on AS in independent cohorts 37 .”
Demers, K., Abdoun, K., Pibarot, P., Tastet, L., Ali, M., Salaun, E., Poirier, P., Powers, A., Sanchez Dahl, J., Beaudoin, J., et al. (2025) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.124.017913 · Cited by 3 · cited 1×
“A recent pilot case-control study demonstrated that angiotensin receptor blockers (ARBs) significantly slow aortic valve calcification progression in patients with mild to moderate aortic stenosis, with the strongest benefit observed in women 49 .”
Self-citationBiomarkers Associated with Aortic Stenosis and Structural Bioprosthesis Dysfunction
Oury, C., Côté, N., & Clavel, M.-A. (2020) · Cardiology Clinics · doi:10.1016/j.ccl.2019.09.005 · Cited by 2 · cited 1×
“Circulating proteins involved in lipid metabolism, inflammation, tissue remodeling, hemostasis and mineralization have been associated with AS 8 .”
Self-citation
Metadata
- Authors
- Zamani, P., Houessou, U., Manikpurage, H. D., Dahmene, M., Li, Z., Gaudreault, N., Clavel, M.-A., Pibarot, P., Mathieu, P., Arsenault, B. J., Eslami, A., Bossé, Y., & Thériault, S.
- Affiliations
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Corresponding author
- Thériault, Sébastien
- ORCID
- Venue
- medRxiv
- Publisher
- openRxiv
- Published
- 2025-11-30
- OpenAlex
- W4416830976
- Semantic Scholar
- b52c60c1c0dcdaac8e3e133d1fd88259a5a6ce02
- Cited by
- 0
- References
- 49
- Type
- posted content
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- medRxiv (acceptedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Aortic Disease and Treatment Approaches
- Keywords
- aortic stenosis, plasma protein biomarkers, GDF15, PCSK9, YKL-40, LTBP2, sex differences, protein quantitative trait loci, expression quantitative trait loci, causal inference, disease incidence, risk prediction, therapeutic target, aortic valve calcification
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.